Topics

Clovis Oncology Announces Availability and Reimbursement for Rubraca (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in France

04:04 EST 3 Feb 2020 | FinanzNachrichten

Rubraca (rucaparib) offers a new monotherapy maintenance treatment option for eligible women with relapsed, platinum-sensitive ovarian cancer, who harbor either a BRCA1/2 mutation or are BRCA wild...

Original Article: Clovis Oncology Announces Availability and Reimbursement for Rubraca (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in France

NEXT ARTICLE

More From BioPortfolio on "Clovis Oncology Announces Availability and Reimbursement for Rubraca (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in France"

Quick Search

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...